WallStSmart

Concentra Group Holdings Parent, Inc. (CON)vsFresenius Medical Care Corporation (FMS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Fresenius Medical Care Corporation generates 807% more annual revenue ($19.63B vs $2.16B). CON leads profitability with a 7.7% profit margin vs 5.0%. FMS trades at a lower P/E of 11.2x. FMS earns a higher WallStSmart Score of 62/100 (C+).

CON

Buy

59

out of 100

Grade: C

Growth: 8.0Profit: 7.0Value: 8.3Quality: 4.8
Piotroski: 2/9

FMS

Buy

62

out of 100

Grade: C+

Growth: 5.3Profit: 5.0Value: 10.0Quality: 7.0
Piotroski: 6/9Altman Z: 1.82
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CONUndervalued (+60.3%)

Margin of Safety

+60.3%

Fair Value

$60.84

Current Price

$22.01

$38.83 discount

UndervaluedFair: $60.84Overvalued
FMSUndervalued (+73.4%)

Margin of Safety

+73.4%

Fair Value

$90.32

Current Price

$22.26

$68.06 discount

UndervaluedFair: $90.32Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CON4 strengths · Avg: 9.0/10
Return on EquityProfitability
48.1%10/10

Every $100 of equity generates 48 in profit

EPS GrowthGrowth
60.1%10/10

Earnings expanding 60.1% YoY

P/E RatioValuation
16.8x8/10

Attractively priced relative to earnings

Revenue GrowthGrowth
15.9%8/10

15.9% revenue growth

FMS3 strengths · Avg: 9.3/10
P/E RatioValuation
11.2x10/10

Attractively priced relative to earnings

Price/BookValuation
0.4x10/10

Reasonable price relative to book value

PEG RatioValuation
0.738/10

Growing faster than its price suggests

Areas to Watch

CON2 concerns · Avg: 3.0/10
Profit MarginProfitability
7.7%3/10

7.7% margin — thin

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

FMS4 concerns · Avg: 3.5/10
EPS GrowthGrowth
4.2%4/10

4.2% earnings growth

Altman Z-ScoreHealth
1.824/10

Grey zone — moderate risk

Return on EquityProfitability
7.9%3/10

ROE of 7.9% — below average capital efficiency

Profit MarginProfitability
5.0%3/10

5.0% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : CON

The strongest argument for CON centers on Return on Equity, EPS Growth, P/E Ratio. Revenue growth of 15.9% demonstrates continued momentum.

Bull Case : FMS

The strongest argument for FMS centers on P/E Ratio, Price/Book, PEG Ratio. PEG of 0.73 suggests the stock is reasonably priced for its growth.

Bear Case : CON

The primary concerns for CON are Profit Margin, Piotroski F-Score.

Bear Case : FMS

The primary concerns for FMS are EPS Growth, Altman Z-Score, Return on Equity. Thin 5.0% margins leave little buffer for downturns.

Key Dynamics to Monitor

CON profiles as a growth stock while FMS is a value play — different risk/reward profiles.

CON is growing revenue faster at 15.9% — sustainability is the question.

FMS generates stronger free cash flow (564M), providing more financial flexibility.

Monitor MEDICAL CARE FACILITIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

FMS scores higher overall (62/100 vs 59/100). CON offers better value entry with a 60.3% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Concentra Group Holdings Parent, Inc.

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Concentra Group Holdings Parent, Inc. (Ticker: CON) is a diversified holding company focused on acquiring and managing businesses across high-growth sectors, including healthcare, technology, and infrastructure. Committed to operational excellence and innovative solutions, Concentra enhances its portfolio through proactive management and strategic investments. With a seasoned leadership team at the helm, the company is strategically positioned to seize emerging trends and capitalize on opportunities within rapidly evolving markets, presenting an appealing investment option for institutional investors seeking exposure to high-potential industries.

Fresenius Medical Care Corporation

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America and internationally. The company is headquartered in Bad Homburg, Germany.

Visit Website →

Want to dig deeper into these stocks?